Olema Pharmaceuticals(OLMA) - 2025 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 Olema Pharmaceuticals, Inc. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) 780 Brannan Street San Francisco, California 94103 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Cod ...